EAM Investors LLC lowered its stake in Cutera, Inc. (NASDAQ:CUTR) by 27.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 122,140 shares of the medical device company’s stock after selling 45,993 shares during the period. Cutera makes up 0.7% of EAM Investors LLC’s investment portfolio, making the stock its 11th largest position. EAM Investors LLC’s holdings in Cutera were worth $5,539,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of CUTR. Parallel Advisors LLC purchased a new position in shares of Cutera during the third quarter worth $117,000. State of Alaska Department of Revenue purchased a new position in shares of Cutera during the fourth quarter worth $125,000. Legal & General Group Plc raised its holdings in shares of Cutera by 69.6% during the third quarter. Legal & General Group Plc now owns 3,600 shares of the medical device company’s stock worth $149,000 after purchasing an additional 1,477 shares during the last quarter. Nationwide Fund Advisors raised its holdings in shares of Cutera by 8.4% during the second quarter. Nationwide Fund Advisors now owns 7,216 shares of the medical device company’s stock worth $187,000 after purchasing an additional 561 shares during the last quarter. Finally, Alambic Investment Management L.P. purchased a new position in shares of Cutera during the fourth quarter worth $204,000. 93.03% of the stock is owned by institutional investors and hedge funds.
In other Cutera news, EVP Miguel Pardos sold 10,000 shares of Cutera stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $46.70, for a total value of $467,000.00. Following the completion of the transaction, the executive vice president now owns 39,698 shares of the company’s stock, valued at $1,853,896.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider James A. Reinstein sold 7,175 shares of Cutera stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $45.35, for a total transaction of $325,386.25. Following the completion of the transaction, the insider now directly owns 132,284 shares of the company’s stock, valued at approximately $5,999,079.40. The disclosure for this sale can be found here. Insiders sold 24,018 shares of company stock valued at $1,104,766 in the last ninety days. 3.30% of the stock is owned by corporate insiders.
Cutera (NASDAQ:CUTR) last issued its earnings results on Wednesday, February 14th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.33 by $0.09. Cutera had a net margin of 19.80% and a return on equity of 18.31%. The firm had revenue of $47.60 million during the quarter, compared to analysts’ expectations of $43.96 million. During the same quarter last year, the company posted $0.30 earnings per share. The firm’s revenue was up 25.6% compared to the same quarter last year. analysts anticipate that Cutera, Inc. will post 1.1 earnings per share for the current fiscal year.
Several research analysts recently issued reports on CUTR shares. Zacks Investment Research cut shares of Cutera from a “hold” rating to a “sell” rating in a report on Tuesday, December 26th. BidaskClub raised shares of Cutera from a “hold” rating to a “buy” rating in a report on Tuesday, December 12th. Maxim Group reissued a “hold” rating on shares of Cutera in a report on Wednesday, November 8th. Finally, Gabelli reissued a “buy” rating on shares of Cutera in a report on Friday, February 16th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $41.25.
TRADEMARK VIOLATION WARNING: This piece was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3226092/cutera-inc-cutr-shares-sold-by-eam-investors-llc.html.
Cutera Company Profile
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR).
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.